In-depth biotech analysis articles

In Depth 23 Apr 2025

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in on FDA approval.

April 23, 2025 - 9 minutesmins - By Willow Shah-Neville

In Depth 17 Apr 2025

Biomaterials in construction: meet the startups reinventing our buildings

We will explore the various biomaterials making a mark in the construction field and how biotechs could potentially transform a carbon-intensive industry.

April 17, 2025 - 11 minutesmins - By Roohi Mariam Peter

In Depth 14 Apr 2025

Metabolomics: The study of biology’s dark matter

Learn about metabolomics, biology’s fourth language that has remained vastly untapped up until now and could accelerate biotech research.

April 14, 2025 - 7 minutesmins - By Jules Adam

In Depth 11 Apr 2025

Basel: What’s behind the success of one of Europe’s leading biotech hubs?

Find out what makes Basel’s biotech hub so successful, as it has cemented its place as one of Europe’s brightest life sciences ecosystems.

April 11, 2025 - 7 minutesmins - By Willow Shah-Neville

In Depth 9 Apr 2025

Cystic fibrosis: is the next blockbuster a gene therapy?

Learn about the biotechs progressing their gene therapies for cystic fibrosis and why it might just be the breakthrough that patients need.

April 9, 2025 - 10 minutesmins - By Roohi Mariam Peter

In Depth 7 Apr 2025

Will tRNA therapy be the next big thing in genetic disease treatment?

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

April 7, 2025 - 12 minutesmins - By Willow Shah-Neville

In Depth 2 Apr 2025

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer’s disease treatments.

April 2, 2025 - 10 minutesmins - By Jules Adam

In Depth 1 Apr 2025

The biggest biotech funding rounds in March 2025

The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.

April 1, 2025 - 4 minutesmins - By Willow Shah-Neville

In Depth 26 Mar 2025

A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations

Delve into the kinase inhibitors’ diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

March 26, 2025 - 9 minutesmins - By Jules Adam

In Depth 19 Mar 2025

Breast cancer treatments heat up: Five therapies poised to transform patient outcomes

Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different approaches.

March 19, 2025 - 11 minutesmins - By Willow Shah-Neville

In Depth 17 Mar 2025

How biotechs are using AI to rescue failed drugs

Discover how biotech companies like Ignota Labs and BioXcel Therapeutics are using AI to rescue failed drugs.

March 17, 2025 - 10 minutesmins - By Willow Shah-Neville

In Depth 14 Mar 2025

Can GLP-1 agonists help treat addiction?

Discover how researchers have been exploring the potential of GLP-1 drugs for treating addiction disorders.

March 14, 2025 - 9 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

In Depth

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval

Biomaterials in construction: meet the startups reinventing our buildings

Metabolomics: The study of biology’s dark matter

Basel: What’s behind the success of one of Europe’s leading biotech hubs?

Cystic fibrosis: is the next blockbuster a gene therapy?

Will tRNA therapy be the next big thing in genetic disease treatment?

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

The biggest biotech funding rounds in March 2025

A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations

Breast cancer treatments heat up: Five therapies poised to transform patient outcomes

How biotechs are using AI to rescue failed drugs

Can GLP-1 agonists help treat addiction?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!